乙肝疫苗出生剂量接种后不良事件防范与应对框架
2016年7月工作组基于中国和越南媒体报道婴儿死亡影响接种覆盖率的案例,利用现有资源制定六步框架(三步准备、三步应对),供国家和区域免疫规划人员使用。
要点
- 框架含三步准备与三步应对,适用于乙肝疫苗出生剂量接种后AEFI的防范与回应。
- 使用前需熟悉本国AEFI的发现、报告和调查机制。
- 目标读者为国家和区域免疫规划人员及疫苗安全监管人员。
核心结论
- 对乙肝疫苗出生剂量接种后报告的不良事件,需以科学严谨的调查和有效风险沟通维持公众对免疫规划的信任。
研究设计与样本
- 2016年7月成立工作组,基于中国和越南媒体报道婴儿死亡影响接种覆盖率的案例,利用现有资源制定框架。
主要发现
- 乙肝疫苗接种是预防HBV母婴传播最有效方法,出生后24小时内及时接种出生剂量尤为关键。
- 新生儿期婴儿死亡风险最高,出生后24小时内接种HepB-BD与婴儿最脆弱时期重叠。
关键数值与推荐
- 框架包括六个步骤,其中三步为准备步骤、三步为应对步骤。
- 使用框架前,工作人员应熟悉本国AEFI的检测、报告和调查方式。
临床怎么用
- 国家和区域免疫规划人员可依据六步框架准备和回应HepB-BD接种后报告的AEFI。
- 国家疫苗安全监管人员可参考该文件开展疫苗安全监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The success of immunization programs in lowering the incidence of vaccine preventable diseases (VPDs) has led to increased public attention on potential health risks associated with vaccines. As a result, a scientifically rigorous response to investigating reported adverse events following immunization (AEFI) and effective risk communications strategies are critical to ensure public confidence in immunization. Globally, an estimated 257 million people have chronic hepatitis B virus (HBV) infection, which causes more than 686,000 premature deaths from liver cancer and cirrhosis. Hepatitis B vaccination is the most effective way to prevent mother-to-child transmission of HBV infection, especially when a timely birth dose is given within 24 h of birth. However, an infant's risk of dying is highest in the neonatal period, and thus, administering HepB-BD within 24 h of birth overlaps with the most fragile period in an infant's life. A working group formed in July 2016 following the publication of the case reports of the effects on vaccination coverage of media reports of infant deaths after HepB-BD administration in China and Vietnam. The goal of the working group was to create a framework and describe best practices for preparing for and responding to AEFI reported after HepB-BD administration, using existing resources. The framework includes six steps, including three preparation steps and three response steps. This document is written for national and regional immunization program staff. Prior to using the framework for preparation and response to AEFIs reported after HepB-BD administration, staff members should be familiar with how AEFI are detected, reported, and investigated in the country. The document might also be of interest to national regulatory staff members who monitor vaccine safety within the country.
引用
- Gidudu JF, Shaum A, Habersaat K, et al. An approach for preparing and responding to adverse events following immunization reported after hepatitis B vaccine birth dose administration. Vaccine. 2019. PMID: 31337590. doi:10.1016/j.vaccine.2019.07.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。